Members of the cystatin superfamily interact with MMP-9 and protect it from autolytic degradation without affecting its gelatinolytic activities

被引:53
作者
Ray, S [1 ]
Lukyanov, P [1 ]
Ochieng, J [1 ]
机构
[1] Meharry Med Coll, Dept Biochem, Nashville, TN 37208 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2003年 / 1652卷 / 02期
关键词
cystatin; matrix; metalloproteinase; fetuin-A; autolysis;
D O I
10.1016/j.bbapap.2003.08.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs), like other proteinases, can undergo autolytic degradation once activated in vivo. Whereas the activities of these enzymes are tightly regulated by tissue inhibitors of matrix metalloproteinases (TIMPs), it is not clear mechanistically how these enzymes are protected from autolysis in their active state. We previously reported that MMPs particularly MMP-9 and MMP-2 interact with the serum glycoprotein fetuin-A [Arch. Biochem. Biophys. (1995) 322, 250], a member of the cystatin superfamily. In the present analyses, we demonstrate that this interaction protects MMP-9 from autolytic degradation without interfering with its enzymatic activity, allowing it to efficiently digest gelatin. Our data demonstrate that MMP-9 binds to members of the cystatin family with K-diss ranging from 25 to 58 nM for fetuin-A and 1.5 - 1.9 muM for cystatin C. The ability of fetuin-A to protect MMP-9 from autolysis requires a molar ratio of at least 8:1 (fetuin-A/MMP-9). More interestingly, our data show that the other members of the cystatin also have the ability to protect MMP-9 from autolysis, provided they are in molar excess relative to MMP-9. Taken together, our data suggest that cystatins, particularly fetuin-A, in any cellular compartment including the circulatory system, efficiently protect MMP-9 and possibly other MMPs from autolysis. This mechanism ensures the digestion of the preferred substrate for MMP-9 without sacrificing the enzyme in the process. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 56 条
[1]  
Björk I, 1998, BIOCHEM J, V335, P701
[2]   Structural studies of matrix metalloproteinases [J].
Borkakoti, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (05) :261-268
[3]   FETUIN - AN OLD FRIEND REVISITED [J].
BROWN, WM ;
SAUNDERS, NR ;
MOLLGARD, K ;
DZIEGIELEWSKA, KM .
BIOESSAYS, 1992, 14 (11) :749-755
[4]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[5]   Matrix metalloproteinases and the development of cancer [J].
Coussens, LM ;
Werb, Z .
CHEMISTRY & BIOLOGY, 1996, 3 (11) :895-904
[6]  
Cugno M, 1999, THROMB HAEMOSTASIS, V82, P1428
[7]   Salivary (SD-type) cystatins: Over one billion years in the making-but to what purpose? [J].
Dickinson, DP .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (06) :485-508
[8]   MATRIX METALLOPROTEINASES AND CARDIOVASCULAR-DISEASE [J].
DOLLERY, CM ;
MCEWAN, JR ;
HENNEY, AM .
CIRCULATION RESEARCH, 1995, 77 (05) :863-868
[9]  
DZIEGIELEWSKA KM, 1990, J BIOL CHEM, V265, P4354
[10]   Type I collagen stabilization of matrix metalloproteinase-2 [J].
Ellerbroek, SM ;
Wu, YI ;
Stack, MS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 390 (01) :51-56